Search Login Register

ropinirole (Requip) Summary

Description: dopamine D2 receptor agonist; structure given in first source; RN given refers to parent; USAN name is ropinirole hydrochloride

Also Known As: Requip; 4-(2-(di-n-propylamino)ethyl)-2(3H)-indolone; GlaxoSmithKline brand of ropinirole hydrochloride; SK&F 101468; SK&F-101,468 Show All >>

Networked: 322 relevant articles (49 outcomes, 105 trials/studies) for this Drug

Key Diseases for which ropinirole is Relevant

  1. Parkinson Disease (Parkinson's Disease) : 28 outcomes 66 studies in 188 results
  2. Dyskinesias (Dyskinesia) : 11 outcomes 16 studies in 60 results
  3. Restless Legs Syndrome (Restless Legs) : 9 outcomes 24 studies in 66 results
  4. Nausea : 1 outcome 3 studies in 19 results
  5. Tremor (Tremors) : 1 outcome 1 study in 6 results
Show All >>

Drugs Related to ropinirole

  1. Levodopa (L Dopa)
  2. Dopamine Agonists (Dopamine Agonist)
  3. pramipexol (pramipexole)
  4. Bromocriptine (Parlodel)
  5. Dopamine (Intropin)
  6. Ergolines
  7. cabergoline
  8. N 0437
  9. ropinirole (Requip)
  10. U 95666E
Show All >>

Therapies Related to ropinirole

  1. Activities of Daily Living (ADL)
  2. Aftercare (After-Treatment)
  3. Renal Dialysis (Hemodialysis)
  4. Oral Administration
  5. Transdermal Patch
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.